(CNNE) Cannae Holdings - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US13765N1072

Restaurants, Healthcare, Financial Services

EPS (Earnings per Share)

EPS (Earnings per Share) of CNNE over the last years for every Quarter: "2020-09": 1.44, "2020-12": 5.85, "2021-03": -2.55, "2021-06": 1.94, "2021-09": -1.36, "2021-12": -1.24, "2022-03": -2.88, "2022-06": -3.15, "2022-09": 0.69, "2022-12": 0.35, "2023-03": -0.05, "2023-06": -1.16, "2023-09": -2.18, "2023-12": -0.83, "2024-03": -1.27, "2024-06": -2.49, "2024-09": -0.22, "2024-12": -0.74, "2025-03": -1.81, "2025-06": -3.75, "2025-09": -1.06,

Revenue

Revenue of CNNE over the last years for every Quarter: 2020-09: 139.7, 2020-12: 170.4, 2021-03: 171.9, 2021-06: 202.4, 2021-09: 186, 2021-12: 181.9, 2022-03: 167.4, 2022-06: 174.5, 2022-09: 164.5, 2022-12: 155.7, 2023-03: 154.3, 2023-06: 152.8, 2023-09: 143.6, 2023-12: 119.3, 2024-03: 110.7, 2024-06: 118, 2024-09: 113.9, 2024-12: 109.9, 2025-03: 103.2, 2025-06: 110.2, 2025-09: 106.9,

Dividends

Dividend Yield 4.10%
Yield on Cost 5y 1.74%
Yield CAGR 5y 0.00%
Payout Consistency 100.0%
Payout Ratio -
Risk via 10d forecast
Volatility 29.3%
Value at Risk 5%th 47.1%
Relative Tail Risk -2.33%
Reward TTM
Sharpe Ratio -0.82
Alpha -38.23
CAGR/Max DD -0.28
Character TTM
Hurst Exponent 0.569
Beta 0.885
Beta Downside 0.992
Drawdowns 3y
Max DD 37.35%
Mean DD 21.00%
Median DD 21.84%

Description: CNNE Cannae Holdings November 16, 2025

Cannae Holdings, Inc. (NYSE:CNNE) is a Las Vegas-based principal investment firm founded in 2014. It deploys capital across a multi-sector portfolio-including restaurant chains, technology-enabled healthcare services, and financial services-taking both minority and majority equity positions.

Key metrics that analysts monitor include CNNE’s cash-on-cash return (historically targeting 12-15% IRR) and its portfolio turnover rate, which has averaged roughly 1.8 ×  per year since inception. The firm’s exposure to consumer discretionary (restaurants) is sensitive to discretionary spending trends, while its technology-enabled healthcare assets benefit from rising tele-health adoption, a sector projected to grow at a CAGR of ~14% through 2028. Additionally, CNNE’s financial services investments are linked to the broader credit market environment, where net interest margin compression could pressure returns.

For a deeper dive into CNNE’s valuation metrics and scenario analysis, you might explore the ValueRay platform.

Piotroski VR‑10 (Strict, 0-10) 1.5

Net Income (-466.3m TTM) > 0 and > 6% of Revenue (6% = 25.8m TTM)
FCFTA -0.03 (>2.0%) and ΔFCFTA 0.32pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 31.26% (prev 28.27%; Δ 2.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA -0.03 (>3.0%) and CFO -40.6m > Net Income -466.3m (YES >=105%, WARN >=100%)
NO Net Debt/EBITDA fails (EBITDA <= 0)
Current Ratio 2.03 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (54.7m) change vs 12m ago -12.34% (target <= -2.0% for YES)
Gross Margin -2.91% (prev 3.03%; Δ -5.94pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 22.64% (prev 20.20%; Δ 2.44pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio -17.22 (EBITDA TTM -222.7m / Interest Expense TTM 14.5m) >= 6 (WARN >= 3)

Altman Z'' 0.38

(A) 0.09 = (Total Current Assets 265.1m - Total Current Liabilities 130.6m) / Total Assets 1.51b
(B) 0.08 = Retained Earnings (Balance) 123.5m / Total Assets 1.51b
(C) -0.13 = EBIT TTM -249.7m / Avg Total Assets 1.90b
(D) 0.40 = Book Value of Equity 132.3m / Total Liabilities 331.6m
Total Rating: 0.38 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 21.07

1. Piotroski 1.50pt
2. FCF Yield -6.17%
3. FCF Margin -11.48%
4. Debt/Equity 0.17
5. Debt/Ebitda 0.11
6. ROIC - WACC (= -21.64)%
7. RoE -30.34%
8. Rev. Trend -95.58%
9. EPS Trend -17.03%

What is the price of CNNE shares?

As of November 29, 2025, the stock is trading at USD 16.10 with a total of 438,179 shares traded.
Over the past week, the price has changed by +2.29%, over one month by -13.16%, over three months by -13.09% and over the past year by -23.76%.

Is CNNE a buy, sell or hold?

Cannae Holdings has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy CNNE.
  • Strong Buy: 1
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CNNE price?

Issuer Target Up/Down from current
Wallstreet Target Price 20.5 27.3%
Analysts Target Price 20.5 27.3%
ValueRay Target Price 15.5 -3.5%

CNNE Fundamental Data Overview November 24, 2025

Market Cap USD = 824.4m (824.4m USD * 1.0 USD.USD)
P/E Forward = 74.0741
P/S = 1.9164
P/B = 0.6726
Beta = 1.135
Revenue TTM = 430.2m USD
EBIT TTM = -249.7m USD
EBITDA TTM = -222.7m USD
Long Term Debt = 61.7m USD (from longTermDebt, last quarter)
Short Term Debt = 22.1m USD (from shortTermDebt, last quarter)
Debt = 210.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -23.7m USD (from netDebt column, last quarter)
Enterprise Value = 800.7m USD (824.4m + Debt 210.1m - CCE 233.8m)
Interest Coverage Ratio = -17.22 (Ebit TTM -249.7m / Interest Expense TTM 14.5m)
FCF Yield = -6.17% (FCF TTM -49.4m / Enterprise Value 800.7m)
FCF Margin = -11.48% (FCF TTM -49.4m / Revenue TTM 430.2m)
Net Margin = -108.4% (Net Income TTM -466.3m / Revenue TTM 430.2m)
Gross Margin = -2.91% ((Revenue TTM 430.2m - Cost of Revenue TTM 442.7m) / Revenue TTM)
Gross Margin QoQ = 5.80% (prev -15.25%)
Tobins Q-Ratio = 0.53 (Enterprise Value 800.7m / Total Assets 1.51b)
Interest Expense / Debt = 1.57% (Interest Expense 3.30m / Debt 210.1m)
Taxrate = 5.94% (-3.80m / -64.0m)
NOPAT = -234.9m (EBIT -249.7m * (1 - 5.94%)) [loss with tax shield]
Current Ratio = 2.03 (Total Current Assets 265.1m / Total Current Liabilities 130.6m)
Debt / Equity = 0.17 (Debt 210.1m / totalStockholderEquity, last quarter 1.21b)
Debt / EBITDA = 0.11 (negative EBITDA) (Net Debt -23.7m / EBITDA -222.7m)
Debt / FCF = 0.48 (negative FCF - burning cash) (Net Debt -23.7m / FCF TTM -49.4m)
Total Stockholder Equity = 1.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -30.79% (Net Income -466.3m / Total Assets 1.51b)
RoE = -30.34% (Net Income TTM -466.3m / Total Stockholder Equity 1.54b)
RoCE = -15.62% (EBIT -249.7m / Capital Employed (Equity 1.54b + L.T.Debt 61.7m))
RoIC = -13.95% (negative operating profit) (NOPAT -234.9m / Invested Capital 1.68b)
WACC = 7.70% (E(824.4m)/V(1.03b) * Re(9.28%) + D(210.1m)/V(1.03b) * Rd(1.57%) * (1-Tc(0.06)))
Discount Rate = 9.28% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -11.66%
Fair Price DCF = unknown (Cash Flow -49.4m)
EPS Correlation: -17.03 | EPS CAGR: 1.78% | SUE: -0.66 | # QB: 0
Revenue Correlation: -95.58 | Revenue CAGR: -13.22% | SUE: 0.21 | # QB: 0

Additional Sources for CNNE Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle